# B. Braun receives FDA approval for new pharmaceutical manufacturing plant in Daytona Beach

B. Braun Medical Inc. received FDA approval for its new pharmaceutical manufacturing plant in Daytona Beach, Florida. The site will produce 0.9% Sodium Chloride for Injection in IV bags, with product deliveries expected to begin in late February 2022.

- Type: Expansion
- Announced: 2022-01-28
- Where: Daytona Beach, Florida, United States
- Starts operating: Feb 2022
- Status: completed
- Products: 0.9% Sodium Chloride for Injection in IV bags
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [B.Braun Medical](https://endata.com/companies/26840.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/b-braun-receives-fda-approval-of-daytona-beach-pharmaceutical-manufacturing-site-301470695.html), 2022-01-28: "B. Braun Medical Inc. ... announced that the company has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical manufacturing plant in Daytona Beach, FL."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.